Objective: To investigate the renoprotective effect of nicardipine in patients with pre-existing renal insufficiency undergoing robot-assisted laparoscopic radical prostatectomy (RALRP). Methods: Men with preoperative renal insufficiency (estimated glomerular filtration rate [eGFR] <60 ml/min per 1.73 m 2 ) were enrolled and randomized to receive either 0.5 mg/kg per min nicardipine continuous infusion (nicardipine group) or normal saline (control group) during RALRP. Renal function was determined by eGFR and serum creatinine concentration. Results: Serum creatinine levels on postoperative days (POD) 1 and 3 were significantly lower than baseline values in the nicardipine group (n ¼ 50). In the control group (n ¼ 50), eGFR was significantly higher on POD 3 than baseline, and was significantly higher than baseline on POD 1 and 3 in the nicardipine group. The change in eGFR from baseline to POD 1 was significantly higher in the nicardipine group than the control group. Conclusion: Continuous infusion of nicardipine during RALRP improved postoperative renal function on POD 1 in patients with pre-existing renal insufficiency.
Introduction
The minimally invasive nature of robotassisted laparoscopic radical prostatectomy (RALRP) limits blood loss, reduces fluid shift, decreases cardiac workload, lowers the frequency of complications, and shortens hospital stay compared with conventional open surgical methods. 1 These features make RALRP an ideal treatment option with low risks of morbidity and mortality in patients with comorbid diseases, including renal insufficiency. 2 Pneumoperitoneum (essential for visualization during RALRP) has several side effects, including reductions in urine output, creatinine clearance, glomerular filtration rate (GFR) and renal blood flow, leading to the aggravation of renal dysfunction during or immediately after laparoscopic surgery. 3, 4 Rats with impaired kidney function have been shown to exhibit increased sensitivity to the deleterious renal effects of pneumoperitoneum compared with normal animals. 5 The 30 head-down tilt required for adequate visualization also results in a pronounced increase in central venous pressure and may further compromise renal perfusion and renal function. 6 The calcium channel blocker nicardipine preferentially dilates renal arterioles and increases GFR, 7, 8 and we have shown that continuous infusion of low dose nicardipine during RALRP attenuates the development of renal insufficiency in the immediate postoperative period. 9 Patients with preoperative renal insufficiency were excluded from that study, however.
The aim of this prospective, randomized, controlled study was to use estimated GFR (eGFR) to investigate the renoprotective effect of nicardipine in patients with renal insufficiency undergoing RALRP.
Patients and methods

Study population
The study enrolled male patients with preoperative renal insufficiency (eGFR <60 ml/ min per 1.73 m 2 ) who were scheduled to undergo RALRP between June 2011 and January 2012 at Yonsei University Severance Hospital, Seoul, Republic of Korea. Patients with eGFR !60 ml/min per 1.73 m 2 were excluded from the study. The institutional review board of Yonsei University Medical Center approved the study and all subjects provided written informed consent prior to enrolment.
Study design
Patients were randomly allocated to either the control or nicardipine groups using a computer generated randomization method. According to the double-blind methodology, the patients, anaesthesia provider and the anaesthetist collecting the data were blinded to the composition of the study groups. An independent researcher prepared the syringes containing the study drug.
Anaesthesia and surgery
On the patient's arrival at the operating theatre, standard monitoring devices were applied and a 20 G catheter was inserted into the radial artery under local anaesthesia to enable arterial pressure monitoring and blood sampling. Anaesthesia was induced using 2 mg/kg propofol i.v. and tracheal intubation was facilitated using 0.6 mg/kg rocuronium i.v. The patient's lungs were mechanically ventilated with 50% oxygen in air at a tidal volume of 8-10 ml/kg and a respiratory rate of 8-12 breaths/min to maintain an end-tidal carbon dioxide of 30-37 mmHg throughout surgery.
After induction of anaesthesia, patients in the nicardipine group received 0.5 mg/kg per min nicardipine continuous intravenous infusion, and those in the control group received the same volume of normal saline throughout the duration of surgery (until anaesthesia was reversed). Infusions were carried out using an Orchestra Õ infusion device (Fresenius Kabi, Bad Homburg, Germany). Anaesthesia was maintained with 0.1-0.2 mg/kg per min remifentanil continuous intravenous infusion and 1-3% sevoflurane. Ringer's lactate solution and normal saline were infused at a rate of 10 ml/kg per h throughout surgery.
Pneumoperitoneum was induced by carbon dioxide insufflation (12) (13) (14) (15) and patients were positioned in a 30 headdown tilt. The robotic system (da Vinci Õ Surgical System, Intuitive Surgical Inc., Mountain View, CA, USA) was controlled via telemanipulation by a surgeon at the master console. Pneumoperitoneum was released after the removal of the prostate.
Data collection
Intra-abdominal pressure and the duration of pneumoperitoneum and anaesthesia were recorded. Mean arterial pressure, heart rate and central venous pressure were recorded and arterial blood gas analyses were performed at three time points: prepneumoperitoneum (10 min after intubation, before surgical incision and with the patient in the neutral position); pneumoperitoneum (1 h after the induction of pneumoperitoneum, with the patient in the 30 head-down tilt position); and postpneumoperitoneum (20 min after the release of pneumoperitoneum).
Serum creatinine and haemoglobin were quantified every day at 06:00 hours, and the corresponding eGFRs were calculated 1 day before surgery (baseline) and on postoperative days (POD) 1 and 3. The highest serum creatinine concentration during the postoperative hospital stay was recorded. Postoperative urine output was recorded for 3 days. Ringer's lactate solution was infused at 1-2 ml/kg per h during the postoperative period. Postoperative data were analysed by an investigator (H.H.) who was blinded to the composition of the study groups.
Statistical analyses
Data were expressed as mean AE SD or n. Sample size was calculated based on eGFR SDs from an earlier study. 10 It was determined that 49 patients were required in each group to give a power of 80% to detect an eGFR of 10 ml/min per 1.73 m 2 and an -level of 0.05, using the independent t-test. Between-group comparisons were made using 2 
Results
The study enrolled 100 male patients (mean age 69 AE 6 years; age range 49-81 years) who were randomly allocated between the control and nicardipine groups (n ¼ 50 per group). Demographic and preoperative clinical data are shown in Table 1 and intraoperative data are shown in Table 2 . There were no statistically significant betweengroup differences in demographic, or preand intra-operative data.
Postoperative data are shown in Table 3 . In the nicardipine group, serum creatinine concentrations were significantly lower than baseline at POD 1 and POD 3 (P < 0.05 for both comparisons), but there were no significant postoperative changes in the control group. There were no significant betweengroup differences in serum creatinine concentrations at any timepoint, highest serum creatinine concentration, or the number of patients with postoperative serum creatinine >1.4 mg/ml (Table 3) .
At POD 1 and POD 3, eGFR was significantly higher than baseline in the nicardipine group (P < 0.05 for both comparisons; Table 3 ). In addition, eGFR was significantly higher on POD 3 compared with baseline in the control group (P < 0.05; Table 3 ). There were no significant betweengroup differences in eGFR at any timepoint, however. The change in eGFR from baseline to POD 1 was significantly higher in the nicardipine group than the control group (P < 0.05).
There were no significant between-group differences in urine output or change in haemoglobin concentration (Table 3) .
No major postoperative complications requiring repeat surgery or postoperative intensive care occurred in either group.
Discussion
Continuous infusion of nicardipine during RALRP increased postoperative eGFR in the present study of patients with renal insufficiency. This increase in eGFR was significantly different from the control group at postoperative day 1. Low-dose nicardipine (0.5 mg/kg per min) appears to attenuate the deleterious effects of pneumoperitoneum and the marked head-down tilt in the immediate postoperative period after RALRP.
There is a strong correlation between eGFR <60 ml/min per 1.73 m 2 and postoperative morbidity and mortality. 11 Following open surgical procedures, the morbidity and mortality of patients with renal failure reach almost 50% and 4%, respectively. 12 In addition, the immunocompromised status of patients with renal failure increases their risk of wound infections. 13 Minimally invasive surgery is rapidly replacing open procedures in many areas of surgery owing to the advantages it offers (reduced blood loss, lower incidence of complications, and shorter hospital stay 1 ), Data are mean AE SD or n.
No statistically significant between-group differences (P ! 0.05; Student's t-test or 2 test). ACEI, angiotensin-converting enzyme inhibitor; AIIRB, angiotensin II receptor blocker. and the risks of morbidity, mortality and wound complications decrease significantly in patients with renal failure who are treated with RALRP rather than open surgery. 13 In spite of the advantages of RALRP, deleterious effects are associated with the increase in abdominal pressure that is secondary to pneumoperitoneum. Pneumoperitoneum and the marked head-down tilt are essential for greater surgical visualization in RALRP, 6, 14 but pneumoperitoneum induces renovascular, caval and renal parenchymal compression, [15] [16] [17] [18] and reduces renal blood flow and urine output in animal models. 15, 16, 19 A worsening of renal function in association with pneumoperitoneum has also been reported in humans following laparoscopic procedures. 3, 4, 20, 21 Extreme head-down tilting markedly increases central venous pressure and compromises renal perfusion during laparoscopic procedures. 22, 23 There is a lack of consensus regarding the renoprotective effects of drugs. Low-dose dopamine has been shown to have a renoprotective effect during laparoscopic surgery, 4 but others report that dopamine and mannitol do not prevent renal dysfunction during laparoscopic surgery. 24, 25 Nicardipine has been shown to act predominantly on the renal afferent arterioles, decreasing total renal vascular resistance and increasing renal blood flow and GFR. 26 During pneumoperitoneum, renal vasoconstriction increases afferent and efferent arteriolar resistance, thereby decreasing renal blood flow. 27 In patients without renal insufficiency, continuous infusion of nicardipine (0.5 mg/kg per min) during RALRP was found to preserve eGFR and attenuate the development of renal insufficiency in the immediate postoperative period. 9 Diminished renal blood flow during pneumoperitoneum and its return to normal flow after deflation have been shown to lead to ischaemia-reperfusion injury. [28] [29] [30] Such ischaemia-reperfusion injury has been associated with increased levels of reactive oxygen species in the kidney, 31 where glomeruli are considerably more sensitive to oxidative injuries than any other segments of the nephron. 32 Elevated calcium ion levels are a key factor in apoptosis and necrosis. 33 L-type calcium channel blockers have been shown to inhibit the calcium ion influx induced by anoxia, resulting in the inhibition of ischemia-reperfusioninduced apoptosis. 34 Clinically, L-type calcium channel blockers prevent acute tubular necrosis and delay the onset of renal failure. 35 Nicardipine, an L-type calcium channel blocker, reduces calcium ion levels and protects tubular cells from apoptosis and necrosis. 34, 36, 37 In the present study, we used the lowest possible dose of nicardipine (0.5 mg/kg per min 38 ) in order to avoid possible hypotension and subsequent renal hypoperfusion. Although this dose of nicardipine was found to have beneficial effects in this and our previous study, 9 further investigation of the optimal nicardipine dosage that maximizes renoprotection while retaining stable haemodynamics is required. In addition, the cryoprotective mechanism of nicardipine remains to be elucidated.
In conclusion, we found that a continuous infusion of nicardipine at a dose of 0.5 mg/kg per min led to significantly better postoperative renal function on postoperative day 1 than control in patients with preexisting renal insufficiency. Nicardipine may prevent the aggravation of renal dysfunction immediately after RALRP.
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